Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Perry

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Toxicologic Pathology|April 3, 2012
An atypical case of islet cell hyperplasia in a Wistar ratNorimitsu Shirai, Alexandros Papanikolaou, Rick Perry
Toxicologic Pathology|March 28, 2013
Society of Toxicologic Pathology position paper on best practices on recovery studies: the role of the anatomic pathologistRick Perry, Georgia Farris, Jean-Guy Bienvenu, et al.
Toxicologic Pathology|February 19, 2013
Renal tumors in male rats following long-term administration of bazedoxifene, a tissue-selective estrogen receptor modulatorRick Perry, Carol A Thompson, J Nicole Earnhardt, et al.
Toxicologic Pathology|September 13, 2007
Society of Toxicologic Pathology position paper: organ weight recommendations for toxicology studiesRani S Sellers, Daniel Morton, Bindhu Michael, et al.
Toxicologic Pathology|September 13, 2007
Evaluation of organ weights for rodent and non-rodent toxicity studies: a review of regulatory guidelines and a survey of current practicesBindhu Michael, Barry Yano, Rani S Sellers, et al.
Toxicologic Pathology|May 3, 2007
Society of Toxicologic Pathology position paper on pathology image data: compliance with 21 CFR Parts 58 and 11Darrell L Tuomari, Ramon K Kemp, Rani Sellers, et al.
Toxicologic Pathology|November 15, 2022
Scientific and Regulatory Policy Committee Best Practices: Recommended ("Best") Practices for Informed (Non-blinded) Versus Masked (Blinded) Microscopic Evaluation in Animal Toxicity StudiesBrad Bolon, Sabine Francke, Jessica M Caverly Rae, et al.
Toxicologic Pathology|April 30, 2020
Opinion on Current Use of Non-Blinded Versus Blinded Histopathologic Evaluation in Animal Toxicity StudiesBrad Bolon, Jessica M Caverly Rae, Karyn Colman, et al.
Toxicologic Pathology|March 6, 2024
Guide for Combining Primary Tumors for Statistical Analysis in Rodent Carcinogenicity StudiesCharlotte Keenan, Muthafar Al-Haddawi, Jean-Guy Bienvenu, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 2014
Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trialsFiona Sewell, Kathryn Chapman, Paul Baldrick, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Toxicologic Pathology|April 3, 2012
An atypical case of islet cell hyperplasia in a Wistar ratNorimitsu Shirai, Alexandros Papanikolaou, Rick Perry
Toxicologic Pathology|March 28, 2013
Society of Toxicologic Pathology position paper on best practices on recovery studies: the role of the anatomic pathologistRick Perry, Georgia Farris, Jean-Guy Bienvenu, et al.
Toxicologic Pathology|February 19, 2013
Renal tumors in male rats following long-term administration of bazedoxifene, a tissue-selective estrogen receptor modulatorRick Perry, Carol A Thompson, J Nicole Earnhardt, et al.
Toxicologic Pathology|September 13, 2007
Society of Toxicologic Pathology position paper: organ weight recommendations for toxicology studiesRani S Sellers, Daniel Morton, Bindhu Michael, et al.
Toxicologic Pathology|September 13, 2007
Evaluation of organ weights for rodent and non-rodent toxicity studies: a review of regulatory guidelines and a survey of current practicesBindhu Michael, Barry Yano, Rani S Sellers, et al.
Toxicologic Pathology|May 3, 2007
Society of Toxicologic Pathology position paper on pathology image data: compliance with 21 CFR Parts 58 and 11Darrell L Tuomari, Ramon K Kemp, Rani Sellers, et al.
Toxicologic Pathology|November 15, 2022
Scientific and Regulatory Policy Committee Best Practices: Recommended ("Best") Practices for Informed (Non-blinded) Versus Masked (Blinded) Microscopic Evaluation in Animal Toxicity StudiesBrad Bolon, Sabine Francke, Jessica M Caverly Rae, et al.
Toxicologic Pathology|April 30, 2020
Opinion on Current Use of Non-Blinded Versus Blinded Histopathologic Evaluation in Animal Toxicity StudiesBrad Bolon, Jessica M Caverly Rae, Karyn Colman, et al.
Toxicologic Pathology|March 6, 2024
Guide for Combining Primary Tumors for Statistical Analysis in Rodent Carcinogenicity StudiesCharlotte Keenan, Muthafar Al-Haddawi, Jean-Guy Bienvenu, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 2014
Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trialsFiona Sewell, Kathryn Chapman, Paul Baldrick, et al.
Pageof 1